A Study to Evaluate Safety, Tolerability, and Immunogenicity of V350A and V350B in Healthy Participants (V350-001).

NCT06655324 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

250

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

BIOLOGICAL: V350A
BIOLOGICAL: V350B
BIOLOGICAL: Placebo

Sponsor

Merck Sharp & Dohme LLC